Delivery Order SPE2DB20D3303-SPE2DB24FA1QV

Award Date 7/31/24
Potential Completion Date 8/1/24
Potential Value $7.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx (secukinumab) 300 milligram dose syringes. The contract has a ceiling value of $9,389.20 and runs through August 21, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of the specialty medication Cosentyx (Secukinumab) 300 mg dose. The contract has a ceiling value of $3,406.81 and an ultimate completion date of July 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the specialty medication Cosentyx (Secukinumab) 300 mg dose. The contract has a total ceiling value of $7,904.77 and a period of performance through August 2, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx 300 mg injectable medication. The firm-fixed-price contract has a ceiling value of $13,982.82 and runs through November 23, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and covering a wide range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx (secukinumab) 300mg dose injectable pens. The contract has a ceiling value of $40,454.43 and an ultimate completion date of September 16, 2024. It is a firm-fixed-price contract, which indicates the government has agreed to pay a predetermined amount for the product regardless of the contractor's actual costs. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg autoinjectors. The contract has a total ceiling value of $7,918.67 and a period of performance through September 6, 2024. AmerisourceBergen, as a major pharmaceutical distributor, provides a wide range of medical products and supplies to various government agencies and healthcare programs. This contract award is part of a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of the pharmaceutical product Cosentyx (secukinumab) in 300 mg doses. The ceiling value of the contract is $9,131.72, and it has a completion date of July 25, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and will be responsible for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cosentyx (secukinumab) 300 mg dosage pens, a specialty medication used for various medical conditions. The contract has a ceiling value of $21,495.87 and runs through June 27, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx, a specialty medication, at a ceiling value of $7,808.37. The contract runs from January 2, 2025, to January 3, 2025, and is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Cosentyx (secukinumab) 300 mg medication. The delivery order, valued at $3,465.90, is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that has a ceiling value of up to $999,999,999 through December 2025. This IDC enables DLA to efficiently procure a comprehensive range of pharmaceutical and medical...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA1QV
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Cosentyx (secukinumab) 300 mg injections. The contract has a ceiling value of $7,793.90 and an ultimate completion date of August 1, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, that serve as primary vehicles for the company to provide a wide range of pharmaceutical and medical supplies to support military treatment programs and other federal healthcare needs nationwide.

Generated 10/30/24, 9:16 AM